- InvestInvestment SuiteExclusiveFeatures
- PlatformProduct SuiteFeatures and ToolsCalculatorsPricing
- ResearchResearch CallsResearch Reports
- MarketStocksIndicesMutual FundsIPO
- LearnResourceInvesting GuideEvents
- Partner
- Support
Invest
Platform
Research
Market
Learn
Compare Tata India Pharma & Healthcare Fund vs ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
Fund Comparison
Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Fund Details
Risk | Very High | Very High |
Rating | 4.0 | 5.0 |
Min SIP Amount | ₹100 | ₹100 |
Expense Ratio | 2.14 | 1.92 |
NAV | ₹30.88 | ₹38.83 |
Fund Started | 04 Dec 2015 | 25 Jun 2018 |
Fund Size | ₹1213.92 Cr | ₹5044.63 Cr |
Exit Load | Exit load of 0.25% if redeemed within 30 days. | Exit load of 1% if redeemed within 15 days. |
Risk
Very High
Very High
Rating
4.0
5.0
Min SIP Amount
₹100
₹100
Expense Ratio
2.14
1.92
NAV
₹30.88
₹38.83
Fund Started
04 Dec 2015
25 Jun 2018
Fund Size
₹1213.92 Cr
₹5044.63 Cr
Exit Load
Exit load of 0.25% if redeemed within 30 days.
Exit load of 1% if redeemed within 15 days.
Returns
1 Year | 39.62% | 45.80% |
3 Year | 21.88% | 25.04% |
5 Year | 27.51% | 30.41% |
1 Year
39.62%
45.80%
3 Year
21.88%
25.04%
5 Year
27.51%
30.41%
Holding Analysis
Equity | 95.72% | 97.27% |
Cash | 4.28% | 2.73% |
Equity
95.72%
97.27%
Cash
4.28%
2.73%
Top Holdings
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 11.80% |
Aurobindo Pharma Ltd. | 7.71% |
Lupin Ltd. | 6.93% |
Cipla Ltd. | 6.19% |
Dr. Reddy's Laboratories Ltd. | 6.09% |
Divi's Laboratories Ltd. | 5.34% |
Fortis Healthcare Ltd. | 4.64% |
Zydus Lifesciences Ltd. | 3.75% |
Alkem Laboratories Ltd. | 3.50% |
Apollo Hospitals Enterprise Ltd. | 3.31% |
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 13.77% |
Dr. Reddy's Laboratories Ltd. | 8.48% |
Cipla Ltd. | 7.94% |
Aurobindo Pharma Ltd. | 5.04% |
Gland Pharma Ltd. | 4.38% |
Lupin Ltd. | 4.29% |
Alkem Laboratories Ltd. | 4.16% |
Zydus Lifesciences Ltd. | 3.10% |
Apollo Hospitals Enterprise Ltd. | 2.93% |
Biocon Ltd. | 2.39% |
Fund Manager
Name | Meeta Shetty | Dharmesh Kakkad |
Start Date | 09 Nov 2018 | 23 Feb 2021 |
Name
Meeta Shetty
Dharmesh Kakkad
Start Date
09 Nov 2018
23 Feb 2021
About Fund
Description | The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India. | The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies. |
Launch Date | 04 Dec 2015 | 25 Jun 2018 |
Description
The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Launch Date
04 Dec 2015
25 Jun 2018
